Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms

Cytotherapy

Volumn 14, Issue 10, 2012, Pages 1171-1181

  Shohara, Ryutaro ^a   Yamamoto, Akihito ^a   Takikawa, Sachiko ^a   Iwase, Akira ^a   Hibi, Hideharu ^a   Kikkawa, Fumitaka ^a   Ueda, Minoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

anti infl ammatory M2 macrophage; human umbilical cord perivascular cells; mesenchymal stromal cells; wound healing

Indexed keywords

5' NUCLEOTIDASE; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; CD11B ANTIGEN; COLLAGEN; ENDOGLIN; INTERLEUKIN 10; PROTEIN; RESISTIN; RESISTIN LIKE MOLECULE ALPHA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR 1; VASCULOTROPIN;

ADIPOGENESIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE EXPRESSION; GRANULATION TISSUE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD PERIVASCULAR CELL TRANSPLANTATION; IMMUNOHISTOLOGY; MACROPHAGE; MESENCHYMAL STROMA CELL; MORPHOMETRICS; MOUSE; MYOFIBROBLAST; NEWBORN; NONHUMAN; OSTEOBLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TISSUE REPAIR; WHARTON JELLY; WOUND; WOUND CLOSURE; WOUND HEALING;

EID: 84867647697     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.706705     Document Type: Article

References (41)

1. Singer A J, Clark RA. Cutaneous wound healing. N Engl J Med. 1999; 341: 738-46.
2. Eming S, Hammerschmidt M, Krieg T, Roers A. Interrelation of immunity and tissue repair or regeneration. Sem Cell Devel Biol. 2009; 20: 517-27.
3. Brancato SK, Albina JE. Wound macrophages as key regulators of repair origin, phenotype, and function. Am J Pathol. 2011; 178: 19-25.
4. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest. 2008; 118: 3522-30.
5. Mosser D M, Edwards J P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8: 958-69.
6. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3: 23-35.
7. Troidl C, Mollmann H, Nef H, Masseli F, Voss S, Szardien S, et al. Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J Cell Mol Med. 2009; 13: 3485-96.
8. Bystrom J, Evans I, Newson J, Stables M, Toor I, van Rooijen N, et al. Resolution-phase macrophages possess a unique infl ammatory phenotype that is controlled by cAMP. Blood. 2008; 112: 4117-27.
9. Deonarine K, Panelli MC, Stashower ME, Jin P, Smith K, Slade HB, et al. Gene expression profiling of cutaneous wound healing. JTransl Med. 2007; 5: 11.
10. Imaizumi T, Akita S, Akino K, Hirano A. Acceleration of sensory neural regeneration and wound healing with human mesenchymal stem cells in immunodeficient rats. Stem Cells. 2007; 25: 2956-63.
11. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007; 13: 1299-312.
12. Fu X, Fang L, Li X, Cheng B, Sheng Z. Enhanced woundhealing quality with bone marrow mesenchymal stem cells autografting after skin injury. Wound Repair Regen. 2006; 14: 325-35.
13. Amos PJ, Kapur SK, Stapor PC, Shang HL, Bekiranov S, Khurgel M, et al. Human adipose-derived stromal cells accelerate diabetic wound healing: Impact of cell formulation and delivery. Tissue Engineering Part A. 2010; 16: 1595-606.
14. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, et al. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. JDermatol Sci. 2007; 48: 15-24.
15. Nishino Y, Yamada Y, Ebisawa K, Nakamura S, Okabe K, Umemura E, et al. Stem cells from human exfoliated deciduous teeth (SHED) enhance wound healing and the possibility of novel cell therapy. Cytotherapy. 2011; 13: 598-605.
16. Nishino Y, Ebisawa K, Yamada Y, Okabe K, Kamei Y, Ueda M. Human deciduous teeth dental pulp cells with basic fibroblast growth factor enhance wound healing of skin defect. J Craniofac Surg. 2011; 22: 438-42.
17. Zhang Q Z, Su W R, Shi S H, Wilder-Smith P, Xiang AP, Wong A, et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells. 2010; 28: 1856-68.
18. Wu Y, Zhao R, Tredget E. Concise review. Bone marrowderived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells. 2010; 28: 905-15.
19. Lee E Y, Xia Y, Kim WS, Kim MH, Kim TH, Kim KJ, et al. Hypoxia-enhanced wound-healing function of adiposederived stem cells: Increase in stem cell proliferation and upregulation of VEGF and bFGF. Wound Repair Regen. 2009; 17: 540-7.
20. Herdrich B, Lind R, Liechty K. Multipotent adult progenitor cells: Their role in wound healing and the treatment of dermal wounds. Cytotherapy. 2008; 10: 543-50.
21. Chen L, Tredget E, Wu P, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008; 3:e1886.
22. Wu Y, Chen L, Scott P, Tredget E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007; 25: 2648-59.
23. Baksh D, Yao R, Tuan R S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007; 25: 1384-92.
24. Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells. 2005; 23: 220-9.
25. Zebardast N, Lickorish D, Davies JE. Human umbilical cord perivascular cells (HUCPVC): A mesenchymal cell source for dermal wound healing. Organogenesis. 2010; 6: 197-203.
26. Agata H, Kagami H, Watanabe N, Ueda M. Effect of ischemic culture conditions on the survival and differentiation of porcine dental pulp-derived cells. Differentiation. 2008; 76: 981-93.
27. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 2004; 12: 485-92.
28. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
29. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005; 97: 512-23.
30. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tiss Res. 2003; 314: 15-23.
31. Daley J M, Brancato S K, Thomay AA, Reichner J S, Albina JE. The phenotype of murine wound macrophages. J Leukocyte Biol. 2010; 87: 59-67.
32. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010; 184: 3964-77.
33. Mirza R, DiPietro LA, Koh T J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol. 2009; 175: 2454-62.
34. Park-Min KH, Antoniv TT, Ivashkiv LB. Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology. 2005; 210: 77-86.
35. Kuroda E, Ho V, Ruschmann J, Antignano F, Hamilton M, Rauh MJ, et al. SHIP represses the generation of IL-3- induced M2 macrophages by inhibiting IL-4 production from basophils. J Immunol. 2009; 183: 3652-60.
36. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R, Huffnagle GB, et al. Role of granulocyte macrophage colonystimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol. 2007; 170: 1028-40.
37. Grant V, King AE, Faccenda E, Kelly RW. PGE/cAMP and GM-CSF synergise to induce a pro-tolerance cytokine profile in monocytic cell lines. Biochem Biophys Res Co. 2005; 331: 187-93.
38. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010; 5: E9252.
39. Nemeth K, Leelahavanichkul A, Yuen P ST, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009; 15: 42-49.
40. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b -peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem. 2009; 284: 34342-54.
41. Fam NP, Verma S, Kutryk M, Stewart DJ. Clinician guide to angiogenesis. Circulation. 2003; 108: 2613-8.